Cosmetics company L’Oréal has announced that it has signed an agreement to acquire a majority stake in the British skincare brand Medik8. As part of the transaction, Inflexion, a European mid-market private equity firm, will remain a minority shareholder. The Founder will continue to serve on the board, with the current management committee also remaining in place to ensure continuity.

Founded by scientist Elliot Isaacs, Medik8 is driven by scientific research and innovation, and offers ingredient-led premium skincare to deliver “results without compromise”. Still true to its professional origins, the brand has also evolved towards a diversified omnichannel sales mix across the most prominent online and offline retailers in Europe, with a growing presence in the USA.

This acquisition further strengthens L’Oréal’s Luxe portfolio, adding a premium science-backed skincare brand with a proven track record of success, with strong potential for global growth.

For more information, visit loreal.com.